Pamela J. Potts
Texas Heart Institute Positions
- Administrative Director, Pathology Research Services
Academic & Clinical Affiliations
- CHI St. Luke’s Health-Baylor St. Luke’s Medical Center
Publications
4862227
6TGG26KJ
1
alternatives-to-animal-experimentation
10
date
desc
Potts
2055
https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VWZPJG3L%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Alviar%20et%20al.%22%2C%22parsedDate%22%3A%222012-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAlviar%2C%20C.%20L.%2C%20Tellez%2C%20A.%2C%20Wang%2C%20M.%20et%20al.%20%282012%29.%20Low-dose%20sirolimus-eluting%20hydroxyapatite%20coating%20on%20stents%20does%20not%20increase%20platelet%20activation%20and%20adhesion%20ex%20vivo.%20%26lt%3Bi%26gt%3BJ%20Thromb%20Thrombolysis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B34%26lt%3B%5C%2Fi%26gt%3B%2C%2091%26%23x2013%3B98.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11239-012-0696-8%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11239-012-0696-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Low-dose%20sirolimus-eluting%20hydroxyapatite%20coating%20on%20stents%20does%20not%20increase%20platelet%20activation%20and%20adhesion%20ex%20vivo%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20L.%22%2C%22lastName%22%3A%22Alviar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armando%22%2C%22lastName%22%3A%22Tellez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Potts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doug%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manus%22%2C%22lastName%22%3A%22Tsui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladyslaw%22%2C%22lastName%22%3A%22Budzynski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20E.%22%2C%22lastName%22%3A%22Raizner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20S.%22%2C%22lastName%22%3A%22Kleiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eli%20I.%22%2C%22lastName%22%3A%22Lev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20F.%22%2C%22lastName%22%3A%22Granada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Greg%20L.%22%2C%22lastName%22%3A%22Kaluza%22%7D%5D%2C%22abstractNote%22%3A%22We%20previously%20found%20paclitaxel-eluting%20polymer-coated%20stents%20causing%20more%20human%20platelet-monocyte%20complex%20formation%20than%20bare%20metal%20stents%20in%20vitro.%20Presently%2C%20we%20examined%20patterns%20of%20platelet%20activation%20and%20adhesion%20after%20exposure%20to%206%20nanofilm%20HAp-coated%20%28HAp-nano%29%20stents%2C%206%20HAp-microporous-coated%20%28HAp-micro%29%20stents%2C%205%20HAp%20sirolimus-eluting%20microporous-coated%20%28HAp-SES%29%20stents%20and%205%20cobalt-chromium%20stents%20%28BMS%29%20deployed%20in%20an%20in%20vitro%20flow%20system.%20Blood%20obtained%20from%20healthy%20volunteers%20was%20circulated%20and%20sampled%20at%200%2C%2010%2C%2030%20and%2060%20min.%20By%20flow%20cytometry%2C%20there%20were%20no%20significant%20differences%20in%20P-Selectin%20expression%20between%20the%204%20stent%20types%20%28HAp-nano%20%3D%2032.5%25%3B%20HAp-micro%20%3D%2042.5%25%2C%20HAp-SES%20%3D%2010.23%25%2C%20BMS%20%3D%207%25%20change%20from%20baseline%20at%2060%20min%2C%20p%20%3D%20NS%29%3B%20PAC-1%20antibody%20binding%20%28HAp-nano%20%3D%2011.8%25%3B%20HAp-micro%20%3D%202.9%25%2C%20HAp-SES%20%3D%2018%25%2C%20BMS%20%3D%206.4%25%20change%20from%20baseline%20at%2060%20min%2C%20p%20%3D%20NS%29%20or%20PMC%20formation%20%28HAp-nano%20%3D%2021.6%25%3B%20HAp-micro%20%3D%204%25%2C%20HAp-SES%20%3D%206.6%25%2C%20BMS%20%3D%2017.4%25%20change%20from%20baseline%20at%2060%20min%2C%20p%20%3D%20NS%29.%20The%204%20stent%20types%20did%20not%20differ%20in%20the%20average%20number%20of%20platelet%20clusters%20%26gt%3B10%20%5Cu03bcm%20in%20diameter%20by%20SEM%20%28HAp-nano%20%3D%202.39%20%5Cu00b1%205.75%3B%20HAp-micro%20%3D%202.26%20%5Cu00b1%203.43%3B%20HAp-SES%20%3D%201.93%20%5Cu00b1%203.24%3B%20BMS%20%3D%201.94%20%5Cu00b1%202.41%2C%20p%20%3D%20NS%29.%20The%20majority%20of%20the%20struts%20in%20each%20stent%20group%20were%20only%20mildly%20covered%20by%20platelets%2C%20%28HAp-nano%20%3D%2080%25%2C%20HAp-micro%20%3D%2061%25%2C%20HAp-SES%20%3D%2078%25%20and%20BMS%20%3D%2052.1%25%2C%20p%20%3D%20NS%29.%20The%20HAp-microporous-coated%20stents%20%28ECD%29%20attracted%20slightly%20more%20proteinaceous%20material%20than%20bare%20metal%20stents%20%28HAp-micro%20%3D%2035%25%20struts%20with%20complete%20protein%20coverage%2C%20P%20%26lt%3B%200.0001%20vs.%20other%203%20stent%20types%29.%20In%20conclusion%2C%20biomimetic%20stent%20coating%20with%20nanofilm%20or%20microporous%20hydroxyapatite%2C%20even%20when%20eluting%20low-dose%20sirolimus%2C%20does%20not%20increase%20the%20platelet%20activation%20in%20circulating%20human%20blood%2C%20or%20platelet%20adhesion%20to%20stent%20surface%20when%20compared%20to%20bare%20metal%20stents%20in%20vitro.%22%2C%22date%22%3A%22Jul%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11239-012-0696-8%22%2C%22ISSN%22%3A%221573-742X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%226TGG26KJ%22%5D%2C%22dateModified%22%3A%222018-05-08T13%3A39%3A33Z%22%7D%7D%5D%7D
Alviar, C. L., Tellez, A., Wang, M. et al. (2012). Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis 34, 91–98. https://doi.org/10.1007/s11239-012-0696-8.
